241. Hypertyrosinemia type I Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 14 / Drugs : 7 - (DrugBank : 1) / Drug target gene : 1 - Drug target pathways : 5
Hypertyrosinemia type I and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
| ID | Diseases (Sorted by drug repositionability) |
|---|---|
| 241 | Hypertyrosinemia type I |
| 6 | Parkinson disease |
| 164 | Oculocutaneous albinism |